METHOD FOR CHOOSING THERAPEUTIC APPROACH FOR PATIENTS WITH NEWLY DIAGNOSED INFILTRATIVE PULMONARY TUBERCULOSIS Russian patent published in 2016 - IPC A61N5/67 G01N33/53 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to phthisiology, and can be used for choosing therapeutic approach in patients with newly diagnosed infiltrative pulmonary tuberculosis. That is ensured by clinical and instrumental methods of research and chemotherapy. In addition, immunological analysis is made and content of cytokines of interferon-γ and tumor necrosis factor α is measured. If norm of interferon-γ = 7.33±0.6 pg/ml is exceeded 7 times and more, and/or tumor necrosis factor α TNF-α = 0.75±0.05 pg/ml is exceeded 4.5 times, transcutaneous laser therapy of low intensity is prescribed.

EFFECT: invention enables to eliminate symptoms of tuberculous intoxication and promotes collapse cavities' closure in patients with newly diagnosed infiltrative pulmonary tuberculosis in the stationary stage and in remote period of observation, to reduce the length of staying in hospital and to reduce laser load on patients.

1 cl, 4 ex